PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17034148-3	2006	Further modification led to an extremely potent (Ki(DPP)(-)(IV) = 1.0 nM) and selective (Ki(DPP8) > 30 microM; Ki(DPP9) > 30 microM) clinical candidate, ABT-279, that is orally available, efficacious, and remarkably safe in preclinical safety studies.	dipalmitoylphosphatidylserine	52-55	dipeptidyl peptidase 8	Homo sapiens	92-96	
21711053-2	2011	The availability of a DPP8-selective compound would be highly instrumental for studying and untwining the biological roles of DPP8 and DPP9 and for the disambiguation of biological effects of nonselective DPP-inhibitors that have mainly been ascribed to blocking of DPPIV"s action.	dipalmitoylphosphatidylserine	22-25	dipeptidyl peptidase 8	Homo sapiens	126-130	
21194356-7	2011	The expression of DPPIV and DPP8 was significantly higher in the cardiac microvascular endothelium than in the other ECs, suggesting a more pronounced role of these DPPs in the microvasculature.	dipalmitoylphosphatidylserine	165-169	dipeptidyl peptidase 8	Homo sapiens	28-32